These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 27499367)

  • 1. miR-17 inhibits ovarian cancer cell peritoneal metastasis by targeting ITGA5 and ITGB1.
    Gong C; Yang Z; Wu F; Han L; Liu Y; Gong W
    Oncol Rep; 2016 Oct; 36(4):2177-83. PubMed ID: 27499367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miR-92a inhibits peritoneal dissemination of ovarian cancer cells by inhibiting integrin α5 expression.
    Ohyagi-Hara C; Sawada K; Kamiura S; Tomita Y; Isobe A; Hashimoto K; Kinose Y; Mabuchi S; Hisamatsu T; Takahashi T; Kumasawa K; Nagata S; Morishige K; Lengyel E; Kurachi H; Kimura T
    Am J Pathol; 2013 May; 182(5):1876-89. PubMed ID: 23499550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transforming growth factor (TGF) β1 acted through miR-130b to increase integrin α5 to promote migration of colorectal cancer cells.
    Yi R; Li Y; Wang F; Gu J; Isaji T; Li J; Qi R; Zhu X; Zhao Y
    Tumour Biol; 2016 Aug; 37(8):10763-73. PubMed ID: 26873488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of Ovarian Epithelial Carcinoma Tumorigenesis and Progression by microRNA 106b Mediated through the RhoC Pathway.
    Chen S; Chen X; Xiu YL; Sun KX; Zhao Y
    PLoS One; 2015; 10(5):e0125714. PubMed ID: 25933027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RhoC is a major target of microRNA-93-5P in epithelial ovarian carcinoma tumorigenesis and progression.
    Chen X; Chen S; Xiu YL; Sun KX; Zong ZH; Zhao Y
    Mol Cancer; 2015 Feb; 14(1):31. PubMed ID: 25649143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beta1-integrins partly mediate binding of ovarian cancer cells to peritoneal mesothelium in vitro.
    Strobel T; Cannistra SA
    Gynecol Oncol; 1999 Jun; 73(3):362-7. PubMed ID: 10366461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-335 represents an invasion suppressor gene in ovarian cancer by targeting Bcl-w.
    Cao J; Cai J; Huang D; Han Q; Yang Q; Li T; Ding H; Wang Z
    Oncol Rep; 2013 Aug; 30(2):701-6. PubMed ID: 23708561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of integrin β1 decreases the malignancy of ovarian cancer cells and potentiates anticancer therapy via the FAK/STAT1 signaling pathway.
    Zhang L; Zou W
    Mol Med Rep; 2015 Dec; 12(6):7869-76. PubMed ID: 26497667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MiR-122 inhibits epithelial mesenchymal transition by regulating P4HA1 in ovarian cancer cells.
    Duan Y; Dong Y; Dang R; Hu Z; Yang Y; Hu Y; Cheng J
    Cell Biol Int; 2018 Nov; 42(11):1564-1574. PubMed ID: 30136751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peritoneal and hematogenous metastases of ovarian cancer cells are both controlled by the p90RSK through a self-reinforcing cell autonomous mechanism.
    Torchiaro E; Lorenzato A; Olivero M; Valdembri D; Gagliardi PA; Gai M; Erriquez J; Serini G; Di Renzo MF
    Oncotarget; 2016 Jan; 7(1):712-28. PubMed ID: 26625210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The hypoxia-related microRNA miR-199a-3p displays tumor suppressor functions in ovarian carcinoma.
    Kinose Y; Sawada K; Nakamura K; Sawada I; Toda A; Nakatsuka E; Hashimoto K; Mabuchi S; Takahashi K; Kurachi H; Lengyel E; Kimura T
    Oncotarget; 2015 May; 6(13):11342-56. PubMed ID: 25839163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MiR-136 inhibits gastric cancer-specific peritoneal metastasis by targeting HOXC10.
    Zheng J; Ge P; Liu X; Wei J; Wu G; Li X
    Tumour Biol; 2017 Jun; 39(6):1010428317706207. PubMed ID: 28656883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-203 inhibits ovarian tumor metastasis by targeting BIRC5 and attenuating the TGFβ pathway.
    Wang B; Li X; Zhao G; Yan H; Dong P; Watari H; Sims M; Li W; Pfeffer LM; Guo Y; Yue J
    J Exp Clin Cancer Res; 2018 Sep; 37(1):235. PubMed ID: 30241553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-382 inhibits migration and invasion by targeting ROR1 through regulating EMT in ovarian cancer.
    Tan H; He Q; Gong G; Wang Y; Li J; Wang J; Zhu D; Wu X
    Int J Oncol; 2016 Jan; 48(1):181-90. PubMed ID: 26575700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MiR-125a regulates ovarian cancer proliferation and invasion by repressing GALNT14 expression.
    Yang J; Li G; Zhang K
    Biomed Pharmacother; 2016 May; 80():381-387. PubMed ID: 27133078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Down-regulation of CD9 in human ovarian carcinoma cell might contribute to peritoneal dissemination: morphologic alteration and reduced expression of beta1 integrin subsets.
    Furuya M; Kato H; Nishimura N; Ishiwata I; Ikeda H; Ito R; Yoshiki T; Ishikura H
    Cancer Res; 2005 Apr; 65(7):2617-25. PubMed ID: 15805258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MiR-203 promotes the growth and migration of ovarian cancer cells by enhancing glycolytic pathway.
    Xiaohong Z; Lichun F; Na X; Kejian Z; Xiaolan X; Shaosheng W
    Tumour Biol; 2016 Nov; 37(11):14989-14997. PubMed ID: 27655286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. AlphaV- and beta1-integrin subunits are commonly expressed in malignant effusions from ovarian carcinoma patients.
    Davidson B; Goldberg I; Reich R; Tell L; Dong HP; Trope' CG; Risberg B; Kopolovic J
    Gynecol Oncol; 2003 Aug; 90(2):248-57. PubMed ID: 12893184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-181b promotes ovarian cancer cell growth and invasion by targeting LATS2.
    Xia Y; Gao Y
    Biochem Biophys Res Commun; 2014 May; 447(3):446-51. PubMed ID: 24735543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-141 enhances anoikis resistance in metastatic progression of ovarian cancer through targeting KLF12/Sp1/survivin axis.
    Mak CS; Yung MM; Hui LM; Leung LL; Liang R; Chen K; Liu SS; Qin Y; Leung TH; Lee KF; Chan KK; Ngan HY; Chan DW
    Mol Cancer; 2017 Jan; 16(1):11. PubMed ID: 28095864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.